T. Rowe Price Associates’s GAN Ltd GAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-48,300
Closed -$86K 3090
2025
Q1
$86K Hold
48,300
﹤0.01% 2856
2024
Q4
$88K Hold
48,300
﹤0.01% 2856
2024
Q3
$86K Hold
48,300
﹤0.01% 2848
2024
Q2
$72K Hold
48,300
﹤0.01% 2799
2024
Q1
$62K Hold
48,300
﹤0.01% 2847
2023
Q4
$77K Sell
48,300
-20,300
-30% -$27K ﹤0.01% 2751
2023
Q3
$80K Hold
68,600
﹤0.01% 2704
2023
Q2
$113K Hold
68,600
﹤0.01% 2674
2023
Q1
$89K Hold
68,600
﹤0.01% 2708
2022
Q4
$103K Hold
68,600
﹤0.01% 2714
2022
Q3
$153K Buy
68,600
+33,200
+94% +$101K ﹤0.01% 2623
2022
Q2
$105K Sell
35,400
-3,455
-9% -$12.8K ﹤0.01% 2748
2022
Q1
$187K Buy
38,855
+8,500
+28% +$54.7K ﹤0.01% 2730
2021
Q4
$279K Buy
+30,355
New +$371K ﹤0.01% 2616

Other funds holding GAN

T. Rowe Price Associates's GAN Position: Q2 2025 in Review

T. Rowe Price Associates sold out of GAN Ltd (GAN) in Q2 2025, closing a stake of 48,300 shares — an estimated $86K sold.

T. Rowe Price Associates first reported a position in GAN in Q4 2021 and held it in 14 quarters. The position peaked at $279K in Q4 2021. 1 fund tracked by Wall St. Rank holds GAN as of Q2 2025.

  • T. Rowe Price Associates reported no remaining GAN Ltd position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 48,300 GAN Ltd shares in Q2 2025, an estimated $86K.
  • T. Rowe Price Associates first reported a position in GAN Ltd in Q4 2021 and held it in 14 quarters.
  • T. Rowe Price Associates's GAN Ltd position peaked at $279K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held GAN Ltd as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.